The University of Chicago Header Logo

A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.

A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma. Cancer Biol Ther. 2007 Apr; 6(4):490-3.

View in: PubMed